Scribe IPO

Focused on the development of CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

NASDAQ: SCTX

Buy

Buy Private Stock

Sign up to invest in private companies like Scribe before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Scribe before their IPO.

Overview

Scribe completed their IPO on July 24, 2026. Now that Scribe is a public company, Nasdaq Private Market does not actively track its performance. The data below is for reference before the company’s IPO.

Scribe Therapeutics is focused on the engineering, delivery, and development of next-generation CRISPR molecules to rewrite and repair the underlying cause of genetic disorders.

Sector

Healthcare & Life Sciences

Founded

2017

Headquarters

Alameda, CA

Scribe Funding

Scribe Funding History Pre-IPO

Gain insights into Scribe funding history prior to their IPO, including the funding round, time period, and amount raised.

Financing Round Date Amount Price per share Valuation
Round Date Amount PPS Valuation
Series B Mar 17, 2021 100M
XXXXX
XXXXX
Series A Jan 30, 2019 500K
XXXXX
XXXXX
Series A Oct 01, 2018 20M
XXXXX
XXXXX
Series A Oct 01, 2018 205K
XXXXX
XXXXX

Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market

Buy

Buy Private Stock

Sign up to invest in private companies like Scribe before their IPO.

Sell

Sell Private Stock

Sign up to sell private companies like Scribe before their IPO.

Scribe Management Team

Scribe people and management – Prior to IPO

  • Co-Founder, Scientific Advisor
    Jennifer A. Doudna
  • CSO, Head of Research & Development
    Aarif Khakoo
  • Board Member
    Carl L. Gordon
  • Co-Founder
    Brett Staahl
  • CFO
    David Parrot
  • Board Member
    Behzad Aghazadeh
  • Board Member
    Vijay Pande
  • Co-Founder
    David Savage
  • Co-Founder, CEO, Board Member, President
    Benjamin Oakes
  • Chief Business Officer
    Svetlana Lucas

Investors

Major Scribe investors

  • OrbiMed Advisors

  • RA Capital Management

  • Wellington Management Company

  • Perceptive Advisors

  • Avoro Ventures

  • Menlo Ventures

  • T. Rowe Price

  • Avoro Capital Advisors

  • Andreessen Horowitz

Scribe Valuations & Financials

Looking for private company valuations and share price data?

Nasdaq Private Market Data & Intelligence is the private company valuation database covering 4,000+ venture-backed companies with daily pricing, financing history, and secondary market activity. View real-time NPM data on pre-IPO companies including valuations, private company comparable transactions, and historical share price information — the private company due diligence data sources institutional investors rely on.

Similar Companies

Explore companies

like Scribe

  • Color-Logo

    Color

    Healthcare & Life Sciences

    Physician-ordered genetic testing with comprehensive support, utilizing advanced software and a certified laboratory.

  • Cityblock Health-Logo

    Cityblock

    Healthcare & Life Sciences

    Tech-driven care provider for communities with complex needs.

  • Hinge Health-Logo

    Hinge Health

    Healthcare & Life Sciences

    Digital clinic for back, joint, and muscle pain.

  • Benchling-Logo

    Benchling

    Healthcare & Life Sciences

    Cloud based platform for research and development in biotechnology.

  • Insitro-Logo

    insitro

    Healthcare & Life Sciences

    Drug discovery and development company.

  • Lyra Healthcare-Logo

    Lyra

    Healthcare & Life Sciences

    Digital health startup using technology to connect companies and employees to mental health providers.

  • Carrot Fertility-Logo

    Carrot Fertility

    Healthcare & Life Sciences

    Medical services including egg freezing and in vitro fertilization (IVF).

  • BillionToOne

    Healthcare & Life Sciences

    Developed a DNA molecular counting technology for detecting gene disorders through a blood test.

  • Nutcracker Therapeutics-Logo

    Nutcracker Therapeutics

    Healthcare & Life Sciences

    Develops RNA-based therapeutics using innovative manufacturing and synthesis platform to advance mRNA treatments and formulations.

FAQ

Questions?

We have answers

Buy Scribe Stock

Scribe became publicly traded following its IPO on July 24, 2026, its shares now trade on public stock exchanges under the ticker symbol NASDAQ: SCTX. Before the IPO, Scribe stock was privately held and available only through private market transactions.

If you’re an accredited investor looking to purchase pre-IPO shares in a private company, Nasdaq Private Market can help you get started. Learn more about investing in the private market or sign up for free to explore available opportunities. Learn more about how private company shares trade prior to an IPO on our investors page.

Sell Scribe Stock

Following its IPO on July 24, 2026, Scribe shares trade on public stock exchanges, allowing shareholders to sell stock through a traditional brokerage.

If you currently hold shares in a private company, Nasdaq Private Market may be able to help you explore your sell private company stock. Our platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To understand how employees sell shares before a company goes public, visit the Employee Shareholders page.

 

Scribe Stock Price

Following the IPO, Scribe stock prices can now be viewed publicly on major exchanges. Investors and interested parties can find the current stock price by searching Scribe’s ticker symbol on financial platforms such as Nasdaq.com or through their preferred brokerage platform.

Scribe Stock Ticker Symbol

Following its IPO on July 24, 2026, Scribe stock now trades on public markets under the ticker symbol NASDAQ: SCTX. You can view real-time stock information through widely used financial data platforms.

Criteria to Sell Scribe Stock

Following the Scribe IPO, public shares can be sold through any brokerage.

Nasdaq Private Market works with employees, ex-employees, and other private company shareholders of pre-IPO companies to sell their shares. The Nasdaq Private Market platform provides a secure and compliant way to sell your shares on terms that work for both you and the company. To learn more about how to sell private company stock, visit the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Scribe Stock

Following Scribe’s initial public offering on July 24, 2026, its shares are now listed on a public exchange and available for purchase through a brokerage account. Investors interested in buying Scribe stock can do so through their preferred broker, just as they would with any other publicly traded security.

Nasdaq Private Market continues to work with investors seeking exposure to private company opportunities prior to IPO. Through structured transactions and curated offerings, investors can participate in private market activity before companies enter the public markets.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Scribe Stock Settlement

Since Scribe is now publicly traded, public-market share transfers and settlement occur automatically through a brokerage or exchange.

Nasdaq Private Market supports transfer and settlement for privately held company equity. In order to buy or sell private company stock, share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patented Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Scribe IPO

Scribe completed its IPO on July 24, 2026, and is now publicly available through major financial sources.